Literature DB >> 9063912

Rebound insomnia after abrupt clozapine withdrawal.

J Staedt1, G Stoppe, G Hajak, E Ruther.   

Abstract

Rebound insomnia has been reported upon discontinuation of benzodiazepines. We describe the first case of a sleep polygraphically documented rebound insomnia with an unusual somatic fatigue syndrome after long-term use of clozapine in a 30-year-old schizophrenic male. The withdrawal symptoms occurred the first day after drug discontinuation and could be stopped by readministering clozapine. In our opinion, the sudden occurrence of the withdrawal symptoms cannot be explained by a dopaminergic hypersensitivity or a cholinergic rebound, but indicates an involvement of GABAergic and perhaps antiglutamatergic properties of clozapine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9063912     DOI: 10.1007/bf02274897

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia.

Authors:  K L Drew; W T O'Connor; J Kehr; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1990-10-23       Impact factor: 4.432

3.  Supersensitivity and clozapine withdrawal.

Authors:  K Eklund
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Clozapine withdrawal rebound psychosis.

Authors:  R L Borison; B I Diamond; D Sinha; R P Gupta; P A Ajiboye
Journal:  Psychopharmacol Bull       Date:  1988

5.  Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.

Authors:  G Chouinard; B D Jones
Journal:  Am J Psychiatry       Date:  1980-01       Impact factor: 18.112

6.  Prolonged psychotic relapse after abrupt clozapine withdrawal.

Authors:  M A Parsa; Y H al-Lahham; L F Ramirez; H Y Meltzer
Journal:  J Clin Psychopharmacol       Date:  1993-04       Impact factor: 3.153

7.  [Does clozapine cause dependence?].

Authors:  M Zapletálek; O Preiningerová; H Hanus
Journal:  Agressologie       Date:  1980

8.  Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal.

Authors:  B Ekblom; K Eriksson; L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration.

Authors:  J Staedt; G Stoppe; A Kögler; H Riemann; G Hajak; D L Munz; D Emrich; E Rüther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

10.  Clozapine-induced agranulocytosis: a situation report up to August 1976.

Authors:  B Anderman; R W Griffith
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

View more
  4 in total

1.  Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response.

Authors:  Lila Aboueid; Richard H McCarthy
Journal:  Case Rep Psychiatry       Date:  2016-06-28

Review 2.  Review of withdrawal catatonia: what does this reveal about clozapine?

Authors:  Matthew Lander; Tarun Bastiampillai; Jitender Sareen
Journal:  Transl Psychiatry       Date:  2018-07-31       Impact factor: 6.222

3.  Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?

Authors:  Graham Blackman; Ebenezer Oloyede; Mark Horowitz; Robert Harland; David Taylor; James MacCabe; Philip McGuire
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306

4.  Clozapine-associated severe eosinophilia following lithium rebound neutropenia: A case report.

Authors:  Kota Kikuchi; Norio Yasui-Furukori; Saaya Yokoyama; Chie Hasegawa; Atsuhiko Kokubun; Shinichi Katsukura; Taro Shimizu; Kazutaka Shimoda
Journal:  Neuropsychopharmacol Rep       Date:  2020-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.